144 related articles for article (PubMed ID: 33514684)
21. Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
Gallipoli P; Drummond MW
Eur J Haematol; 2009 Mar; 82(3):242-3. PubMed ID: 19018859
[No Abstract] [Full Text] [Related]
22. Expression of retinoic acid receptor-target genes during retinoic acid therapy for acute promyelocytic leukemia.
Takitani K; Koh M; Zhu CL; Inoue A; Kuno T; Tanoue H; Miyake M; Nakagawa T; Tamai H
Leukemia; 2003 Mar; 17(3):646-8. PubMed ID: 12646960
[No Abstract] [Full Text] [Related]
23. Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia.
Wang Y; Lin D; Wei H; Li W; Liu B; Zhou C; Liu K; Mi Y; Wang J
Int J Hematol; 2015 Mar; 101(3):279-85. PubMed ID: 25563706
[TBL] [Abstract][Full Text] [Related]
24. [Induction therapy of acute promyelocytic leukemia with all-trans retinoic acid: a case, followed by conventional post-remission chemotherapy in complete remission].
Tsukada T; Mahmud N; Taniguchi M; Takahashi T; Kihira H; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1992 Dec; 33(12):1880-3. PubMed ID: 1479702
[TBL] [Abstract][Full Text] [Related]
25. [Acute promyelocytic leukaemia].
Tøstesen M; Østergård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336301
[TBL] [Abstract][Full Text] [Related]
26. Use of all-trans retinoic acid to treat acute promyelocytic leukemia: a case with very severe features at the onset in Nicaragua.
Flores A; Malta A; Pacheco C; Baez F; Ocampo E; Conter V; Masera G; Biondi A; Rovelli A
Med Pediatr Oncol; 1996 Apr; 26(4):258-60. PubMed ID: 8600338
[TBL] [Abstract][Full Text] [Related]
27. Tretinoin for the treatment of acute promyelocytic leukemia.
Wu H
Cancer Pract; 2002; 10(2):109-11. PubMed ID: 11903277
[No Abstract] [Full Text] [Related]
28. Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management.
Dombret H; Castaigne S; Fenaux P; Chomienne C; Degos L
Leukemia; 1994; 8 Suppl 3():S73-5. PubMed ID: 7808030
[TBL] [Abstract][Full Text] [Related]
29. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia.
Jeddi R; Kacem K; Ben Neji H; Mnif S; Gouider E; Aissaoui L; Ben Amor R; Ben Lakhal R; Ben Abid H; Belhadjali Z; Meddeb B
Hematology; 2008 Jun; 13(3):142-6. PubMed ID: 18702871
[TBL] [Abstract][Full Text] [Related]
31. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Asou N
Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
[No Abstract] [Full Text] [Related]
32. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
[TBL] [Abstract][Full Text] [Related]
33. [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia].
Degos L
Presse Med; 1990 Oct; 19(32):1483-4. PubMed ID: 2146649
[No Abstract] [Full Text] [Related]
34. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
Gillis JC; Goa KL
Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
[TBL] [Abstract][Full Text] [Related]
35. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
36. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
[No Abstract] [Full Text] [Related]
37. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
Dang CC; Guan YK; Lau NS; Chan SY
J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute promyelocytic leukaemia in first relapse with all-trans retinoic acid.
Wong K; Lim HL; Teo CP; Tan YO; Kueh YK
Ann Acad Med Singap; 1995 Jan; 24(1):177-9. PubMed ID: 7605089
[TBL] [Abstract][Full Text] [Related]
39. Repeated efficacy of all-trans-retinoic acid in an acute promyelocytic leukemia patient.
Watanabe A; Inokuchi K; Mizuki T; Yamaguchi H; Yokose N; Dan K
Am J Hematol; 2000 Sep; 65(1):87-8. PubMed ID: 10936873
[No Abstract] [Full Text] [Related]
40. Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin.
Mahendra P; Keeling DM; Hood IM; Baglin TP; Marcus RE
Clin Lab Haematol; 1996 Mar; 18(1):51-2. PubMed ID: 9118606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
